Differential Activation of Mitogen-activated Protein Kinases in Ischemic and Anesthetic Preconditioning

Anesthesiology

Volumn 100, Issue 1, 2004, Pages 59-69

  Da Silva, Rafaela ^a   Grampp, Thomas ^a   Pasch, Thomas ^b   Schaub, Marcus C ^a   Zaugg, Michael ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5 HYDROXYDECANOIC ACID; CHELERYTHRINE; ISOFLURANE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANESTHETIC PRECONDITIONING; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART INFARCTION PREVENTION; IMMUNOHISTOCHEMISTRY; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN LOCALIZATION; RAT; REPERFUSION INJURY; SARCOLEMMA; WESTERN BLOTTING;

ANESTHETICS; ANIMALS; BLOTTING, WESTERN; ENZYME ACTIVATION; HEART; HEAT-SHOCK PROTEINS; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENOTYPE; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 0346732959     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200401000-00013     Document Type: Article

References (45)

1. Toller WG, Kersten JR, Gross ER, Pagel PS, Warltier DC: Isoflurane preconditions myocardium against infarction via activation of inhibitory guanine nucleotide binding proteins. ANESTHESIOLOGY 2000; 92:1400-7
2. Uecker M, da Silva R, Grampp T, Pasch T, Schaub MC, Zaugg M: Translocation of protein kinase C isoforms to subcellular targets in ischemic and anesthetic preconditioning. ANESTHESIOLOGY 2003; 99:138-47
3. ATP channels: Reduction of myocardial infarct size with an acute memory phase. ANESTHESIOLOGY 1997; 87: 361-70
4. ATP channels via multiple signaling pathways. ANESTHESIOLOGY 2002; 97:4-14
5. Müllenheim J, Ebel D, Frässdorf J, Preckel B, Thämer V, Schlack W: Isoflurane preconditions myocardium against infarction via release of free radicals. ANESTHESIOLOGY 2002; 96:934-40
6. An J, Varadarajan SG, Novalija E, Stowe DF: Ischemic and anesthetic preconditioning reduces cytosolic [Ca2+] and improves Ca2+ responses in intact hearts. Am J Physiol 2001; 281:H1508-23
7. Riess ML, Camara AK, Novalija E, Chen Q, Rhodes SS, Stowe DF: Anesthetic preconditioning attenuates mitochondrial Ca2+ overload during ischemia in guinea pig intact hearts: Reversal by 5-hydroxydecanoic acid. Anesth Analg 2002; 95:1540-6
8. Toller WG, Kersten JR, Pagel PS, Hettrick DA, Warltier DC: Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. ANESTHESIOLOGY 1999; 91:1437-46
9. Kehl F, Pagel PS, Krolikowski JG, Weidong G, Toller W, Warltier DC, Kersten JR: Isoflurane does not produce a second window of preconditioning against myocardial infarction in vivo. Anesth Analg 2002; 95:1162-8
10. ATP channels. Am J Physiol 2002; 283:H61-8
11. Johnson GL, Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002; 298:1911-12
12. Michel MC, Li Y, Heusch G: Mitogen-activated protein kinases in the heart. Naunyn Schmiedebergs Arch Pharmacol 2001; 363:245-66
13. Mocanu MM, Baxter GF, Yue Y, Critz SD, Yellon DM: The p38 MAPK inhibitor, SB203580, abrogates ischemic preconditioning in rat heart but timing of administration is critical. Basic Res Cardiol 2000; 95:472-8
14. Fryer RM, Patel HH, Husu AK, Gross GJ: Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium. Am J Physiol 2001; 281:H1184-92
15. Fryer RM, Hsu AK, Gross GJ: ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection. Basic Res Cardiol 2001; 96:136-42
16. Caroll R, Yellon DM: Delayed cardioprotection in a human cardiomyocyte-derived cell line: The role of adenosine, p38 MAP kinase, and mitochondrial K(ATP) channel. Basic Res Cardiol 2000; 95:243-9
17. Doble B, Ping P, Kardami E: The epsilon subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation. Circ Res 2000; 86: 293-301
18. Mocanu MM, Bell RM, Yellon DM: PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. J Mol Cell Cardiol 2002; 34:661-8
19. Sakamoto K, Urushidani T, Nagao T: Translocation of HSP 27 to cytoskeleton by repetitive hypoxia-reoxygenation in the rat myoblast cell line, H9c2. Biochem Biophys Res Comm 1998; 251:576-9
20. Zuellig RA, Bornhauser BC, Knuesel I, Fritschy JM, Schaub MC: Identification and characterisation of transcript and protein of a new short N-terminal utrophin isoform. J Cell Biochem 2000; 77:418-31
21. + exchange inhibitor cariporide (HOE 642) on cardiac function and cardiomyocyte cell death in rat ischemic-reperfused hearts. Clin Exp Pharmacol Physiol 2000; 27:387-93
22. Scarabelli T, Stephanou A, Rayment N, Pasini E, Comini L, Curello S, Ferrari R, Knight R, Latchman D: Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 2001; 104:253-6
23. Cope DK, Impastato WK, Cohen MV, Downey JM: Volatile anesthetics protect the ischemic rabbit myocardium from infarction. ANESTHESIOLOGY 1997; 86:699-709
24. Toller WG, Montgomery MW, Pagel PS, Hettrick DA, Warltier DC, Kersten JR: Isoflurane-enhanced recovery of canine stunned myocardium: Role for protein kinase C? ANESTHESIOLOGY 1999; 91:713-22
25. Bueno OF, Molkentin JD: Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res 2002; 91:776-81
26. Steenbergen C: The role of p38 mitogen-activated protein kinase in myocardial ischemia/reperfusion injury: Relationship to ischemic preconditioning. Basic Res Cardiol 2002; 97:276-85
27. Weinbrenner C, Liu GS, Cohen MV, Downey JM: Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol 1997; 29:2383-91
28. Armstrong SC, Delacey M, Ganote CE: Phosphorylation state of hsp27 and p38 MAPK during preconditioning and protein phosphatase inhibitor protection of rabbit cardiomyocytes. J Mol Cell Cardiol 1999; 31:555-67
29. Sato M, Cordis GA, Maulik N, Das DK: SAPKs regulation of ischemic preconditioning. Am J Physiol Heart Circ Physiol 2000; 279:H901-7
30. Sanada S, Kitakaze M, Papst PJ, Hatanaka K, Asanuma H, Aki T, Shinozaki Y, Ogita H, Node K, Takashima S, Asakura M, Yamada J, Fukushima T, Ogai A, Kuzuya T, Mori H, Terada N, Yoshida K, Hori M: Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart. Circ Res 2001; 88:175-80
31. Schulz R, Belosjorow S, Gres P, Jansen J, Michel MC: p38 MAP kinase is a mediator of ischemic preconditioning in pigs. Cardiovasc Res 2002; 55:690-700
32. Barancik M, Htun P, Strohm C, Kilian S, Schaper W: Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death. J Cardiovasc Pharmacol 2000; 35:474-83
33. Ping P, Zhang J, Cao X, Li RC, Kong D, Tang X, Manchikalapudi S, Auchampach JA, Black RG, Bolli R: PKC-dependent activation of p44/42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am J Physiol 1999; 276: H1468-81
34. Strohm C, Barancik T, Bruhl ML, Kilian SA, Schaper W: Inhibition of the ERK-kinase cascade by PD98059 and UO126 counteracts ischemic preconditioning in pig myocardium. J Cardiovasc Pharmacol 2000; 36:218-29
35. Yue TL, Wang C, Gu JL, Ma XL, Kumar S, Lee JC, Feuerstein GZ, Thomas H, Maleeff B, Ohlstein EH: Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused hearts. Circ Res 2000; 86:692-99
36. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, Hewett TE, Jones SP, Lefer DJ, Peng CF, Kitsis RN, Molkentin JD: The MEK1-ERK1/ 2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 2000; 19:6341-50
37. Hunter JJ, Tanaka N, Rockman HA, Ross J, Chien KR: Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem 1995; 270:23173-8
38. Baines CP, Zhang J, Wang GW, Zheng YT, Xiu JX, Cardwell EM, Bolli R, Ping P: Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart. Circ Res 2002; 90:390-7
39. Ping P, Zhang J, Pierce WM, Bolli R: Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection. Circ Res 2001; 88:59-62
40. Garcia-Dorado D, Ruiz-Meana M, Padilla F, Rodrigues-Sinovas A, Mirabet M: Gap junction-mediated intercellular communication in ischemic preconditioning. Cardiovasc Res 2002; 55:456-65
41. Punn A, Mockridge JW, Farooqui S, Marber MS, Heads RJ: Sustained activation of p42/p44 mitogen-activated protein kinase during recovery from simulated ischaemia mediates adaptive cytoprotection in cardiomyocytes. Biochem J 2000; 350:891-9
42. Sakamoto K, Urushidani T, Nagao T: Translocation of HSP27 to sarcomere induced by ischemic preconditioning in isolated rat hearts. Biochem Biophys Res Commun 2000; 269:137-42
43. Young PR, McLaughlin MM, Kumar S, Kassis S, Doyle ML, McNulty D, Gallagher TF, Fisher S, McDonnell PC, Carr SA, Huddleston MJ, Seibel G, Porter TG, Livi GP, Adams JL, Lee JC: Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J Biol Chem 1997; 272:12116-21
44. Clanachan AS, Jaswal JS, Gandhi M, Bottorff DA, Coughlin J, Finegan BA, Stone JC: Effects of inhibition of myocardial extracellular-responsive kinase and p38 mitogen-activated protein kinase on mechanical function of rat hearts after prolonged hypothermic ischemia. Transplantation 2003; 75:173-80
45. Zhong L, Su JY: Isoflurane activates PKC and calcium-calmodulin-dependent protein kinase II via MAP kinase signaling in cultured vascular smooth muscle cells. ANESTHESIOLOGY 2002; 96:148-54